Based on the development of effective liver- and tumor-targeting gene delivery polymeric nanoparticle systems, we studied the efficacy of two anti-angiogenesis genes, Endostatin and HGFK1, on the treatment of the orthotopic HCC-bearing mice. This evidence concerns the gene COL18A1 and hepatocellular carcinoma.